ARTICLE | Clinical News
VibeX riboflavin ophthalmic solution regulatory update
March 12, 2012 7:00 AM UTC
Avedro submitted an NDA to FDA for VibeX riboflavin ophthalmic solution for use with its KXL System for corneal cross-linking to treat keratoconus and corneal ectasia following refractive surgery. Vib...